India Glycols Limited · NSE:INDIAGLYCO
India Glycols — Q1 FY22 Earnings Presentation
41 slides from India Glycols's earnings presentation, Aug 11, 2021
Slide 1: Stock exchange cover letter for investor presentation
0 INDIA GLYCOLS LIMITED ~ VJ ..,i-l l RTt1 1r · ....... \\;:~'-)) !!!!!!!! ISO 9001 ISO 14001 ; ISO 45001 ISO 50 . ..,"" 0 z Plot No. 2-B, Sector -126, NOIDA-201304 , Di stt. Gautam Budh Nagar, Utta r Pradesh , Tel. : +91 120 6860000 , 3090100 , 3090200 Fax : +91 120 3090111 , 3090211 E-mail : iglho
Slide 2: India Glycols Limited Investor Presentation August 2021
India Glycols Limited Investor Presentation August 2021
Slide 3: Safe Harbour Statement
Safe Harbour Statement This presentation may contain statements which reflect the management’s current views and estimates and could be construed as forward-looking statements. These statements are based on certain assumptions and expectations of future events. The company cannot guarantee that thes
Slide 4: Note on JV Transaction
Note on JV Transaction The Board of Directors of the parent Company at their meeting held on 24th June, 2020 had considered and approved transfer of parent Company’s BioEO (Speciality Chemicals) Business to a wholly-owned subsidiary, which was further approved by the members of the parent Company at
Slide 5: Q1 Performance
re INDIA GLYCOLS LIMITED
Slide 6: Financial Highlights – Q1FY22
Financial Highlights – Q1FY22 All Figures in INR Cr unless specified Net Revenue EBITDA & Margin • Q1-FY22 vs Q1-FY21 – strong comeback in all segments with 14.6% 17.0% 973 140 13.4% 16.0% an overall net revenue growth 865 120 131 15.0% 14.0% 13.0% 100 9.0% 12.0% of 124% and EBITDA growth of 11.0% 1
Slide 7: Business Highlights – Q1FY22
Business Highlights – Q1FY22 • JV with Clariant for Bio-Based Ethoxylates concluded successfully. Out of a total consideration of INR 652 Crores, the company has received INR 451 crores, with a profit of INR 240 crores in Q1FY22 • Unilever announces partnership with LanzaTech and India Glycols to pr
Slide 8: Segment-wise Net Revenue
Segment-wise Net Revenue Q1FY22 Q1FY21 Nutraceuticals, 43 , 5% Nutraceuticals, 35 , 9% Ethyl Alcohol, 151 , 17% Ethyl Alcohol, 99 , 26% Industrial Industrial Chemicals Chemicals , , 252 , 672 , 78% 65% Revenue INR 865 Cr Revenue INR 386 Cr India Glycols Limited, Investor Presentation August 2021
Slide 9: Segment Performance & Key Ratios – Q1FY22
Segment Performance & Key Ratios – Q1FY22 (In INR Crs) Q1FY22 Q4FY21 % QoQ Q1FY21 % YoY June March Industrial Chemicals Ratios 2021 2021 Net Revenue 671.6 740.9 -9% 252 166% EBIT 41.3 78.4 -47% 5.9 605% % margin 6.14% 10.58% (455) Bps 2.32% 455 bps Debt Equity Ratio 0.36 0.76 Ethyl Alcohol Fixed Ass
Slide 10: Income Statement (Consolidated)
Income Statement (Consolidated) Particulars (In INR Crs) Q1FY22 Q4FY21 Q-o-Q Change Q1FY21 Y-o-Y Change Revenue from operations (net of excise) 650.7 752.1 -13.5% 292.8 122.3% Other Income 1.3 10.1 -86.9% 1.5 -8.3% Total Income 652.0 762.2 -14.5% 294.2 121.6% Cost of Material Consumed 452.6 541.5 -1
Slide 11: Company Overview
re INDIA GLYCOLS LIMITED
Slide 12: IGL at a glance
IGL at a glance Diversified portfolio with synergies – Bio-based Specialties, Bio-Polymers, Plant Global customer base and partnerships based APIs & Nutraceuticals, Potable with reputed global companies Spirits, Gases, Bio Fuels, CarbonSmart range First company in the world to use innovative green t
Slide 13: Sustainable bio-based ingredients based on green technologies
Sustainable bio-based ingredients based on green technologies Business Divisions JV for Renewable EO derivatives FY21 Financials (in INR) Bio-based chemicals & Specialties Clariant IGL Specialty Gross Turnover • Bio-based Specialties – glycols, glycol Chemicals Private Limited ethers & acetates, spe
Slide 14: Portfolio: Sustainable bio-based ingredients based on green technologies
Portfolio: Sustainable bio-based ingredients based on green technologies Bio-Based Specialities Potable Spirits Nutraceuticals IGL Green JV Unique strength in Bio Ethanol, IMFL, Branded Country Liquor, ENA Expertise in green extraction - Returns through 49% in JV Glycols, EO, Ethers-multi feedstock
Slide 15: Our History in Major Milestones
Our History in Major Milestones 1988 1994 1996 2001 2004 2006 2008 2010 2015 2020 2021 First EO Formulation Guar Gum 1 ENA Glycol E 2 MEG Dehradun Guar Gum Sanitizers JV Distillery Purification Sulphation Glycol E 1 Textile 600 TPD Ennature PO Clariant Guar Gum 1 1 3 5 6 8 10 13 14 16 18 19 1988 199
Slide 16: Bio-Based Chemicals and Specialities
Bio-Based Chemicals and Specialities • Only manufacturer globally to produce bio-ethylene glycols using renewable feedstock i.e. Molasses • Glycol ethers and acetates: Only manufacturer in India to use a continuous process with world-renowned ‘Sulzer Chemtech’ technology. Reliable supply; integratio
Slide 17: Potable Spirits
Potable Spirits • License for operations and sale of Country Liquor in the States of Uttar Pradesh and Uttarakhand. Also operates and sells Indian Made Foreign Liquor (“IMFL”) from its own unit and few tie-up units • Company brands are available in the states of Uttarakhand, Uttar Pradesh, Delhi and
Slide 18: Ennature Biopharma Nutraceuticals
Ennature Biopharma Nutraceuticals • Operates in the space of Nutraceuticals, Phytochemicals & health supplement ingredients. One of the leaders in Complex phytochemicals chemistry in India • Global leader in Thiocolchicoside, a highly potent muscle relaxant API • Advanced production capabilities, in
Slide 19: Catering to diverse end markets
Catering to diverse end markets • Glycols are used for the manufacture of polyester yarn, fibre, film and resin and as an automobile coolant • Bio-glycols cater to the beverage and food industry's packaging requirement of PET bottles and polyester film • Ethyl / Butyl glycol ethers and its acetates,
Slide 20: IGL entered into a 49:51 JV with Clariant
IGL entered into a 49:51 JV with Clariant… • IGL carved out its Bio-EO based ethoxylates Promoters Public and derivatives business to a subsidiary 61.01% 1 38.99% 1 ‘Clariant IGL Specialty Chemicals Pvt. Ltd’. & 1 - Shareholding as on 30th June 2021 inducted Clariant as 51% JV partner • Both compani
Slide 21: JV to become one of the leaders in bio-based ethoxylates and derivatives
… JV to become one of the leaders in bio- based ethoxylates and derivatives By combining production and distribution capacity, the joint venture is expected to become a leading supplier of renewable materials to the rapidly growing consumer care market in India and neighbouring countries Production
Slide 22: A value-generating combination with Clariant
A value-generating combination with Clariant Chairman, Mr U.S. Bhartia’s thoughts on • The JV combines IGL’s renewable bio-ethylene oxide derivatives business, the deal: which includes a multipurpose production facility including an alkoxylation plant located in Kashipur, Uttarakhand, with Clariant’
Slide 23: Operations – key locations
Operations – key locations Kashipur Dehradun Noida HO Gorakhpur India Glycols Limited, Investor Presentation August 2021
Slide 24: Leveraging synergies to create value–integrated manufacturing for bio-based products
Leveraging synergies to create value–integrated manufacturing for bio-based products Power O2, N2, Ar ENA Liquor Sanitizers IGD Alcohol Grain Ind Gr. CO2 Distillery O2 ASU EO-CO2 mix Bio- Bio- Green Bio- Molasses Distillery Ethylene Bio-E O EODs Performance Ethanol Chemicals CarbonSmart- Ethylene CS
Slide 25: Manufacturing Capabilities
Manufacturing Capabilities Kashipur Site Gorakhpur Site 300-acre state of art integrated manufacturing 56-acre state of art distillation and bottling complex complex located in Uttarakhand, India Fermentation Fermentation Ethanol Distillation Ethanol Distillation Ethanol Extra Purification Ethanol E
Slide 26: R&D: Creating value through New Product Development; focus on Green Chemistry
R&D: Creating value through New Product Development; focus on Green Chemistry • R&D focuses on NPD, designing products for the future • DSIR Recognized R&D - Dehradun and Kashipur • Green Chemistry, renewable resources stat-of-art of Processes & Performance-Oriented products: o Green Solvents for In
Slide 27: Market-led innovations in product, process and application technologies
Market-led innovations in product, process and application technologies • Continuously working for: • Maintaining novelty, uniqueness and Technical edge of products • Value creation through Novel approaches of manoeuvring different Chemistries • Value addition through structure activity correlation
Slide 28: Growth drivers
Growth drivers • High prospects of growth of industry sectors being serviced by IGL – Personal Care, Automotive, Packaging, Beverages, Oil & Gas, Home Care, Pharma, Nutraceuticals etc, Textiles – most expected to grow at near double digit or more • Increasing consumer awareness and demand for sustai
Slide 29: 5-year Financial Trajectory
5-year Financial Trajectory In INR Cr unless specified Gross Revenue Net Revenue EBITDA 3,356 3,470 436 6,058 2,948 403 5,951 3,028 359 5,117 335 2,473 3,583 4,155 243 2017 2018 2019 2020 2021 2017 2018 2019 2020 2021 2017 2018 2019 2020 2021 EBITDA Margin (%) PAT Cash Profit 13.0% 12.2% 256 238 233
Slide 30: 5-year Key Ratios
5-year Key Ratios Ratios 2017 2018 2019 2020 2021* Asset Turn Over Ratio 1.07 1.24 1.38 1.48 1.49 Current Ratio 0.63 0.71 0.88 0.87 1.00 Quick Ratio 0.34 0.43 0.48 0.51 0.58 Debt to Equity Ratio 1.07 0.75 0.77 0.70 0.76 Interest Coverage Ratio 2.00 2.85 3.22 2.95 3.21 Capital Employed Turnover Ratio
Slide 31: Sustainability, ESG
Sustainability, ESG Environment Stewardship • World’s first company to produce Bio-Based EO and its derivatives • Largest producer of Bio-based EO and its derivatives • Next Generation CarbonSmart products from emissions (fossil carbon) - collaboration with LanzaTech & consumer majors like UL and Lu
Slide 32: Sustainability, ESG
Sustainability, ESG Management & Ethical System Certifications – sustaining for over a decade 1. ISO 9001:2015 Quality Management 2. ISO 14001: 2015 Environmental Management 3. ISO 45001 : 2018 Occupational Health & Safety Management 4. ISO 50001:2018 Energy Management 5. SA 8000: 2014 Social Accoun
Slide 33: Business Structure, Holdings
Business Structure, Holdings • Kashipur Holdings Limited, the Promoter, holds 38.14% shareholding of Holding India Glycols Limited Company • Promoter/Promoter Group holds 61.01% shareholding • Shakumbari Sugar and Allied Industries Limited • IGL Finance Limited Indian • Clariant IGL Specialty Chemic
Slide 34: Board of Directors
Board of Directors Executive Directors Non-Executive Directors Non-Independent Director: Mr. U. S. Bhartia, Chairman & Managing Director Mrs. Jayshree Bhartia Independent Directors: Mr. Pradip Kumar Khaitan Ms. Pragya Bhartia Barwale Mr. Ravi Jhunjhunwala Mr. Jitender Balakrishnan Mr. Jagmohan N. Ke
Slide 35: Leadership team
Leadership team Mr. Rupark Mr. Anand Prof. Dr. R.K. Mr. Sanjeev Mr. S.K. Shukla, Mr. R.S. Yadav, Mr. Ankur Jain, Sarswat, Singhal, Khandal, Gurwara, Head – Liquor Head Human Head (Legal) & Chief Executive Chief Financial President - R&D President Business Resources Company Officer Officer and Busine
Slide 36: Shareholding pattern: as on 30 June 2021
Shareholding pattern: as on 30 June 2021 FPIs/FIIs/NRIs/ Shareholder Information as on 30th June 2021 OCBs, 2.16% Others, Individual 1.58% BSE Ticker 500201 Public Shareholding, NSE Symbol INDIAGLYCO 27.51% Market Cap (in ₹ Cr) 2,190 % Free-Float 38.99% Financial Institutions/Banks/ Free-Float Marke
Slide 37: Income Statement (Consolidated)
Income Statement (Consolidated) Particulars (In INR Crs) FY21 FY20 Y-o-Y Change Revenue from operations (net of excise) 2,317 2,735 -15.3% Other Income 15.3 8.8 74.2% Total Income 2,332.3 2,744.2 -15.0% Cost of Material Consumed 1,499.17 1,846.0 -18.8% % of Sales 64.7% 67.5% (278.1) bps Employee Ben
Slide 38: Balance Sheet (Consolidated)
Balance Sheet (Consolidated) Particulars (In Rs. Crs) 31-Mar-21 31-Mar-20 Particulars (In Rs. Crs) 31-Mar-21 31-Mar-20 Assets Equity and Liablities Non-current Assets Equity Property, Plant and Equipment 2,171 2,201 Equity Share Capital 31 31 Capital work-in-progress 125.8 171.7 Other Equity 1,138 1
Slide 39: Cash Flow Statement (Consolidated)
Cash Flow Statement (Consolidated) Particulars (In Rs. Crs) 31-Mar-21 31-Mar-20 A) Cash flow from Operating Activities Net Profit / (Loss) Before Tax 119.8 113.1 Operating profit / (Loss) before Working Capital Changes 241.4 291.7 Cash Generated from / (used in) operations 98.7 333.4 Net Cash flow f
Slide 40: India Glycols Limited contact details
India Glycols Limited CIN: L24111UR1983PLC009097 Ankur Jain Company Secretary & Compliance Officer Head office 2B, Sector-126, Noida Gautam Budh Nagar Uttar Pradesh 201304 Tel: +91-120-6860000, 3090100, 3090200 Fax: +91-120-3090111 Email: investor.relations@indiaglycols.com
Slide 41: Thank you
is | INDIA GLYCOLS LIMITED Thank you